1-1 of 1
Robin Weisenborn, MT CCRC
Close
Save search
Sort by
Journal Articles

Low Dose Alemtuzumab (Campath 1H) Prior to Allogeneic Stem Cell Transplantation Is Associated with Low Incidence of Acute and Chronic GVHD but Protracted Immune Recovery.

Free
Marcel P. Devetten, MD, Fausto Loberiza, MD, Robin Weisenborn, MT CCRC, Pam Bunner, MT CCRC, Jamie Brewer, Solveig Ericson, MD
Journal: Blood
Blood (2005) 106 (11): 5376.
https://doi.org/10.1182/blood.V106.11.5376.5376
Published: 2005